SCN5A Gene Long QT syndrome type 3 Genetic Test
Test Cost: AED 4400.0
Components:
- Price: AED 4400.0
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Cardiovascular Pneumology Disorders
- Doctor: Cardiologist
- Test Department: Genetics
Pre Test Information:
Clinical History of Patient who is going for SCN5A Gene Long QT syndrome type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SCN5A Gene Long QT syndrome type 3 NGS Genetic DNA Test gene SCN5A.
Test Details:
The SCN5A gene is associated with the development of Long QT syndrome type 3 (LQT3). LQT3 is a genetic disorder that affects the heart’s electrical system, causing abnormal heart rhythms and an increased risk of sudden cardiac arrest.
NGS (Next-Generation Sequencing) is a technology used to analyze multiple genes simultaneously, including the SCN5A gene, to identify any genetic variations or mutations that may be present. The NGS genetic test for LQT3 specifically looks for mutations in the SCN5A gene that are known to be associated with this type of long QT syndrome.
This genetic test can be helpful in diagnosing individuals with suspected LQT3, as well as in identifying family members who may be at risk of developing the condition. It can also assist in making treatment decisions, such as determining the appropriate medications or interventions to manage the condition and reduce the risk of complications.
It is important to note that this test is typically ordered by a healthcare provider who specializes in genetic testing or cardiology. The results of the test should be interpreted by a healthcare professional with expertise in genetic disorders and cardiac conditions. Genetic counseling may also be recommended to help individuals and their families understand the implications of the test results and make informed decisions about their healthcare.
| Test Name | SCN5A Gene Long QT syndrome type 3 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cardiovascular Pneumology Disorders |
| Doctor | Cardiologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SCN5A Gene Long QT syndrome type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SCN5A Gene Long QT syndrome type 3 NGS Genetic DNA Test gene SCN5A |
| Test Details |
The SCN5A gene is associated with the development of Long QT syndrome type 3 (LQT3). LQT3 is a genetic disorder that affects the heart’s electrical system, causing abnormal heart rhythms and an increased risk of sudden cardiac arrest. NGS (Next-Generation Sequencing) is a technology used to analyze multiple genes simultaneously, including the SCN5A gene, to identify any genetic variations or mutations that may be present. The NGS genetic test for LQT3 specifically looks for mutations in the SCN5A gene that are known to be associated with this type of long QT syndrome. This genetic test can be helpful in diagnosing individuals with suspected LQT3, as well as in identifying family members who may be at risk of developing the condition. It can also assist in making treatment decisions, such as determining the appropriate medications or interventions to manage the condition and reduce the risk of complications. It is important to note that this test is typically ordered by a healthcare provider who specializes in genetic testing or cardiology. The results of the test should be interpreted by a healthcare professional with expertise in genetic disorders and cardiac conditions. Genetic counseling may also be recommended to help individuals and their families understand the implications of the test results and make informed decisions about their healthcare. |
